| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss, Sensorineural | 35 | 2024 | 783 | 6.280 |
Why?
|
| Hearing Loss | 30 | 2022 | 785 | 5.140 |
Why?
|
| Vestibular Aqueduct | 11 | 2023 | 73 | 2.830 |
Why?
|
| Deafness | 20 | 2024 | 460 | 2.590 |
Why?
|
| Audiometry, Pure-Tone | 9 | 2023 | 210 | 1.680 |
Why?
|
| Tonsillectomy | 16 | 2022 | 281 | 1.640 |
Why?
|
| Connexins | 13 | 2023 | 355 | 1.610 |
Why?
|
| Otitis Media | 11 | 2018 | 287 | 1.600 |
Why?
|
| Usher Syndromes | 3 | 2021 | 56 | 1.520 |
Why?
|
| Cochlear Implantation | 12 | 2023 | 317 | 1.510 |
Why?
|
| Cochlear Implants | 12 | 2023 | 342 | 1.390 |
Why?
|
| Hearing Loss, Unilateral | 3 | 2022 | 25 | 1.200 |
Why?
|
| Adenoidectomy | 12 | 2022 | 171 | 1.130 |
Why?
|
| Ear, Middle | 10 | 2015 | 341 | 0.950 |
Why?
|
| Diagnostic Techniques, Otological | 1 | 2021 | 11 | 0.740 |
Why?
|
| Child | 100 | 2023 | 80670 | 0.720 |
Why?
|
| Temporal Bone | 7 | 2015 | 683 | 0.700 |
Why?
|
| Cytomegalovirus Infections | 3 | 2022 | 838 | 0.700 |
Why?
|
| Lymphadenitis | 5 | 2018 | 99 | 0.690 |
Why?
|
| Torticollis | 2 | 2020 | 69 | 0.670 |
Why?
|
| Sexual Harassment | 1 | 2020 | 82 | 0.660 |
Why?
|
| Ear, Inner | 3 | 2015 | 426 | 0.650 |
Why?
|
| Child, Preschool | 78 | 2022 | 42577 | 0.640 |
Why?
|
| Middle Ear Ventilation | 5 | 2018 | 101 | 0.600 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2018 | 19 | 0.600 |
Why?
|
| Otitis Media with Effusion | 8 | 2008 | 115 | 0.580 |
Why?
|
| Infant | 58 | 2023 | 36459 | 0.580 |
Why?
|
| Stomatitis, Aphthous | 4 | 2016 | 51 | 0.570 |
Why?
|
| Blindness | 1 | 2021 | 585 | 0.560 |
Why?
|
| Otolaryngology | 3 | 2022 | 699 | 0.560 |
Why?
|
| Vaccines, Conjugate | 1 | 2018 | 334 | 0.540 |
Why?
|
| Pharyngitis | 4 | 2016 | 221 | 0.520 |
Why?
|
| Hearing Loss, Mixed Conductive-Sensorineural | 2 | 2016 | 13 | 0.510 |
Why?
|
| Retropharyngeal Abscess | 1 | 2015 | 21 | 0.510 |
Why?
|
| Cochlear Nerve | 3 | 2012 | 202 | 0.510 |
Why?
|
| Postoperative Hemorrhage | 3 | 2020 | 418 | 0.500 |
Why?
|
| Vestibular Diseases | 3 | 2021 | 232 | 0.490 |
Why?
|
| Audiometry | 9 | 2016 | 253 | 0.490 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2021 | 1657 | 0.490 |
Why?
|
| Pharyngeal Diseases | 2 | 2015 | 134 | 0.470 |
Why?
|
| Pneumococcal Vaccines | 1 | 2018 | 414 | 0.460 |
Why?
|
| Physicians, Women | 1 | 2020 | 516 | 0.450 |
Why?
|
| Office Visits | 1 | 2018 | 593 | 0.450 |
Why?
|
| Workplace | 1 | 2020 | 873 | 0.450 |
Why?
|
| Speech Perception | 4 | 2023 | 512 | 0.440 |
Why?
|
| Genetic Testing | 9 | 2022 | 3591 | 0.430 |
Why?
|
| Vestibular Function Tests | 5 | 2015 | 128 | 0.420 |
Why?
|
| Deglutition Disorders | 2 | 2018 | 640 | 0.410 |
Why?
|
| Hearing Aids | 3 | 2021 | 58 | 0.410 |
Why?
|
| Membrane Transport Proteins | 6 | 2016 | 1029 | 0.410 |
Why?
|
| Hearing Loss, Sudden | 1 | 2013 | 45 | 0.400 |
Why?
|
| Neck | 3 | 2018 | 736 | 0.400 |
Why?
|
| Hearing Loss, Conductive | 4 | 2016 | 159 | 0.390 |
Why?
|
| Labyrinth Diseases | 3 | 2010 | 151 | 0.390 |
Why?
|
| Alleles | 12 | 2021 | 6896 | 0.380 |
Why?
|
| Hearing | 5 | 2023 | 504 | 0.380 |
Why?
|
| DNA Mutational Analysis | 8 | 2016 | 4114 | 0.370 |
Why?
|
| Cytomegalovirus | 1 | 2015 | 754 | 0.360 |
Why?
|
| Otitis Media, Suppurative | 6 | 1998 | 27 | 0.360 |
Why?
|
| Consensus | 1 | 2021 | 3208 | 0.360 |
Why?
|
| Guideline Adherence | 1 | 2021 | 2233 | 0.350 |
Why?
|
| Hearing Loss, Bilateral | 3 | 2022 | 53 | 0.350 |
Why?
|
| Pedigree | 4 | 2024 | 4539 | 0.350 |
Why?
|
| Adolescent | 53 | 2021 | 88902 | 0.350 |
Why?
|
| Humans | 153 | 2024 | 766812 | 0.330 |
Why?
|
| Adenoids | 2 | 2008 | 35 | 0.330 |
Why?
|
| Mutation | 26 | 2024 | 30214 | 0.320 |
Why?
|
| Tubulin | 2 | 2024 | 694 | 0.320 |
Why?
|
| Genotype | 9 | 2021 | 13036 | 0.320 |
Why?
|
| Cystic Fibrosis | 3 | 2016 | 1285 | 0.320 |
Why?
|
| Retrospective Studies | 42 | 2023 | 81657 | 0.300 |
Why?
|
| Phosphorylcholine | 1 | 2008 | 152 | 0.290 |
Why?
|
| Saccharomyces cerevisiae Proteins | 7 | 2007 | 1836 | 0.290 |
Why?
|
| Cochlea | 5 | 2020 | 848 | 0.290 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2779 | 0.280 |
Why?
|
| Acute Disease | 4 | 2016 | 7240 | 0.280 |
Why?
|
| Infant, Newborn | 25 | 2023 | 26387 | 0.270 |
Why?
|
| Male | 94 | 2024 | 364154 | 0.270 |
Why?
|
| Tomography, X-Ray Computed | 16 | 2015 | 20710 | 0.260 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2008 | 144 | 0.260 |
Why?
|
| Female | 88 | 2024 | 396532 | 0.260 |
Why?
|
| Acetyltransferases | 3 | 2004 | 230 | 0.260 |
Why?
|
| Saccharomyces cerevisiae | 11 | 2006 | 2678 | 0.250 |
Why?
|
| Cost of Illness | 1 | 2015 | 1949 | 0.250 |
Why?
|
| Bacteriophages | 2 | 2020 | 382 | 0.250 |
Why?
|
| Myosins | 2 | 2021 | 407 | 0.250 |
Why?
|
| Music | 1 | 2008 | 248 | 0.240 |
Why?
|
| Semicircular Canals | 3 | 2011 | 203 | 0.240 |
Why?
|
| Vertigo | 3 | 2020 | 205 | 0.240 |
Why?
|
| Young Adult | 20 | 2021 | 59939 | 0.230 |
Why?
|
| Axoneme | 1 | 2024 | 26 | 0.230 |
Why?
|
| Hearing Tests | 2 | 2004 | 123 | 0.230 |
Why?
|
| Vestibular Evoked Myogenic Potentials | 2 | 2023 | 88 | 0.230 |
Why?
|
| Face | 2 | 2021 | 1029 | 0.230 |
Why?
|
| Ciliary Motility Disorders | 1 | 2024 | 51 | 0.220 |
Why?
|
| Centrioles | 1 | 2024 | 80 | 0.220 |
Why?
|
| Acoustic Impedance Tests | 6 | 2009 | 111 | 0.220 |
Why?
|
| Abnormalities, Multiple | 3 | 2021 | 1424 | 0.220 |
Why?
|
| Laryngeal Diseases | 3 | 2000 | 248 | 0.210 |
Why?
|
| Nuclear Envelope | 3 | 2007 | 161 | 0.210 |
Why?
|
| Airway Obstruction | 6 | 2006 | 672 | 0.210 |
Why?
|
| Hearing Disorders | 1 | 2003 | 126 | 0.200 |
Why?
|
| Vestibule, Labyrinth | 2 | 2023 | 235 | 0.200 |
Why?
|
| Ossicular Replacement | 1 | 2002 | 11 | 0.200 |
Why?
|
| Mutation, Missense | 2 | 2024 | 2591 | 0.200 |
Why?
|
| Incus | 1 | 2002 | 19 | 0.200 |
Why?
|
| Neonatal Screening | 3 | 2018 | 619 | 0.200 |
Why?
|
| Anti-Bacterial Agents | 10 | 2018 | 7475 | 0.200 |
Why?
|
| Auditory Threshold | 4 | 2018 | 369 | 0.200 |
Why?
|
| Gene Frequency | 5 | 2021 | 3624 | 0.200 |
Why?
|
| Reflex, Vestibulo-Ocular | 2 | 2015 | 86 | 0.200 |
Why?
|
| Lysine-tRNA Ligase | 1 | 2021 | 5 | 0.190 |
Why?
|
| Chromosome Segregation | 3 | 2015 | 230 | 0.190 |
Why?
|
| CHARGE Syndrome | 1 | 2021 | 34 | 0.190 |
Why?
|
| Genome, Viral | 3 | 2020 | 674 | 0.180 |
Why?
|
| Pain, Postoperative | 3 | 2020 | 1768 | 0.180 |
Why?
|
| Facial Paralysis | 1 | 2005 | 346 | 0.180 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2019 | 216 | 0.180 |
Why?
|
| Genes, Recessive | 4 | 2024 | 625 | 0.180 |
Why?
|
| Electroretinography | 2 | 2021 | 524 | 0.180 |
Why?
|
| Epiglottis | 1 | 2000 | 81 | 0.180 |
Why?
|
| Cholesteatoma | 2 | 1993 | 28 | 0.180 |
Why?
|
| Genome, Human | 4 | 2024 | 4443 | 0.180 |
Why?
|
| Genetic Variation | 7 | 2021 | 6613 | 0.180 |
Why?
|
| Telemedicine | 1 | 2018 | 3111 | 0.180 |
Why?
|
| Visual Field Tests | 2 | 2021 | 415 | 0.170 |
Why?
|
| Audiology | 1 | 2020 | 23 | 0.170 |
Why?
|
| Nuclear Proteins | 7 | 2007 | 5795 | 0.170 |
Why?
|
| Actinobacteria | 1 | 2020 | 62 | 0.170 |
Why?
|
| Cilia | 1 | 2024 | 498 | 0.170 |
Why?
|
| Nursing, Team | 1 | 1999 | 3 | 0.170 |
Why?
|
| Chromatids | 3 | 2004 | 62 | 0.170 |
Why?
|
| Diagnosis, Differential | 9 | 2021 | 12985 | 0.160 |
Why?
|
| Physician Executives | 1 | 2020 | 140 | 0.160 |
Why?
|
| Ibuprofen | 1 | 2020 | 228 | 0.160 |
Why?
|
| Transcription Factor AP-2 | 1 | 2019 | 78 | 0.160 |
Why?
|
| Tracheostomy | 2 | 2000 | 430 | 0.160 |
Why?
|
| Diabetes Insipidus | 1 | 2019 | 144 | 0.150 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7870 | 0.150 |
Why?
|
| Fasciitis, Necrotizing | 1 | 1999 | 79 | 0.150 |
Why?
|
| Tonsillitis | 3 | 2020 | 28 | 0.150 |
Why?
|
| Pediatric Nursing | 1 | 1999 | 104 | 0.150 |
Why?
|
| Clarithromycin | 1 | 2018 | 87 | 0.150 |
Why?
|
| Nuclear Localization Signals | 1 | 1998 | 78 | 0.150 |
Why?
|
| Nuclear Pore Complex Proteins | 2 | 1996 | 165 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2005 | 1043 | 0.150 |
Why?
|
| Arthrobacter | 1 | 2017 | 20 | 0.140 |
Why?
|
| DNA-Binding Proteins | 3 | 2021 | 9613 | 0.140 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 381 | 0.140 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 371 | 0.140 |
Why?
|
| Hematologic Diseases | 1 | 2021 | 502 | 0.140 |
Why?
|
| Mycobacteriophages | 1 | 2017 | 19 | 0.140 |
Why?
|
| Faculty | 1 | 2020 | 383 | 0.140 |
Why?
|
| Prophages | 1 | 2017 | 39 | 0.140 |
Why?
|
| Syndrome | 5 | 2016 | 3271 | 0.140 |
Why?
|
| Cleft Lip | 1 | 2022 | 512 | 0.140 |
Why?
|
| Hearing Loss, Central | 1 | 2016 | 14 | 0.140 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2000 | 527 | 0.140 |
Why?
|
| Retroelements | 1 | 1998 | 162 | 0.140 |
Why?
|
| Laryngoscopy | 5 | 2018 | 714 | 0.130 |
Why?
|
| Cleft Palate | 1 | 2022 | 596 | 0.130 |
Why?
|
| Fungal Proteins | 3 | 2000 | 901 | 0.130 |
Why?
|
| Postoperative Complications | 8 | 2010 | 15831 | 0.130 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2016 | 42 | 0.130 |
Why?
|
| Pharynx | 1 | 1999 | 436 | 0.130 |
Why?
|
| Mycobacterium smegmatis | 1 | 2017 | 126 | 0.130 |
Why?
|
| Fingers | 1 | 2019 | 508 | 0.130 |
Why?
|
| DNA Replication | 1 | 2003 | 1426 | 0.130 |
Why?
|
| Personal Satisfaction | 1 | 2020 | 642 | 0.130 |
Why?
|
| Reoperation | 3 | 2022 | 4325 | 0.130 |
Why?
|
| Phenotype | 10 | 2024 | 16722 | 0.130 |
Why?
|
| Hyperbilirubinemia | 1 | 2015 | 74 | 0.120 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 1995 | 45 | 0.120 |
Why?
|
| Rubella | 1 | 2015 | 55 | 0.120 |
Why?
|
| Integrases | 1 | 1998 | 520 | 0.120 |
Why?
|
| Dizziness | 2 | 2015 | 269 | 0.120 |
Why?
|
| Foreign Bodies | 3 | 2001 | 403 | 0.120 |
Why?
|
| Tracheotomy | 4 | 1995 | 174 | 0.120 |
Why?
|
| Granular Cell Tumor | 1 | 1995 | 48 | 0.120 |
Why?
|
| Toxoplasmosis | 1 | 2015 | 94 | 0.120 |
Why?
|
| Tympanic Membrane | 3 | 2008 | 232 | 0.120 |
Why?
|
| Hoarseness | 1 | 1995 | 63 | 0.120 |
Why?
|
| Membrane Proteins | 5 | 2011 | 7869 | 0.120 |
Why?
|
| Genetic Counseling | 2 | 2010 | 634 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2024 | 2815 | 0.120 |
Why?
|
| Head Injuries, Closed | 1 | 2015 | 133 | 0.120 |
Why?
|
| Physical Examination | 2 | 2018 | 1265 | 0.120 |
Why?
|
| Disease Progression | 4 | 2021 | 13642 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2017 | 913 | 0.110 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2000 | 617 | 0.110 |
Why?
|
| Patient Selection | 4 | 2012 | 4252 | 0.110 |
Why?
|
| Sequence Deletion | 2 | 2011 | 1494 | 0.110 |
Why?
|
| Databases as Topic | 1 | 2015 | 472 | 0.110 |
Why?
|
| Centromere | 3 | 1989 | 214 | 0.110 |
Why?
|
| Chromosomes | 4 | 2006 | 578 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2015 | 36570 | 0.110 |
Why?
|
| Noise | 1 | 2015 | 295 | 0.110 |
Why?
|
| Syphilis | 1 | 2015 | 243 | 0.100 |
Why?
|
| Staphylococcal Infections | 1 | 2022 | 1396 | 0.100 |
Why?
|
| Prosthesis Failure | 1 | 2018 | 1208 | 0.100 |
Why?
|
| Exoribonucleases | 1 | 1993 | 88 | 0.100 |
Why?
|
| Periodicity | 3 | 2012 | 347 | 0.100 |
Why?
|
| Larynx | 1 | 2017 | 492 | 0.100 |
Why?
|
| Fistula | 2 | 1995 | 213 | 0.100 |
Why?
|
| Congenital Abnormalities | 1 | 2017 | 703 | 0.100 |
Why?
|
| Cell Cycle Proteins | 3 | 2021 | 3440 | 0.100 |
Why?
|
| Herpes Simplex | 1 | 2015 | 470 | 0.100 |
Why?
|
| Severity of Illness Index | 5 | 2021 | 15912 | 0.100 |
Why?
|
| Aminoglycosides | 3 | 2009 | 161 | 0.100 |
Why?
|
| Electrocoagulation | 2 | 2011 | 156 | 0.100 |
Why?
|
| Laryngeal Neoplasms | 1 | 1995 | 514 | 0.100 |
Why?
|
| Otologic Surgical Procedures | 3 | 2011 | 148 | 0.100 |
Why?
|
| Pseudomonas Infections | 4 | 1998 | 622 | 0.090 |
Why?
|
| Nose Neoplasms | 2 | 2003 | 250 | 0.090 |
Why?
|
| Genes, Fungal | 1 | 1993 | 441 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 20146 | 0.090 |
Why?
|
| Perilymph | 2 | 1995 | 50 | 0.090 |
Why?
|
| Homozygote | 4 | 2011 | 1775 | 0.090 |
Why?
|
| Visual Acuity | 1 | 2021 | 2714 | 0.090 |
Why?
|
| Leadership | 1 | 2020 | 1394 | 0.090 |
Why?
|
| Cautery | 1 | 2011 | 73 | 0.090 |
Why?
|
| Petrous Bone | 1 | 2011 | 85 | 0.090 |
Why?
|
| Gastroesophageal Reflux | 2 | 2003 | 834 | 0.090 |
Why?
|
| Craniofacial Abnormalities | 2 | 2005 | 320 | 0.090 |
Why?
|
| Device Removal | 2 | 2022 | 643 | 0.090 |
Why?
|
| Genomics | 4 | 2020 | 5922 | 0.090 |
Why?
|
| Genetic Linkage | 1 | 2015 | 2342 | 0.090 |
Why?
|
| Constriction, Pathologic | 2 | 2012 | 1104 | 0.090 |
Why?
|
| Labyrinthine Fluids | 1 | 1989 | 15 | 0.090 |
Why?
|
| Adult | 19 | 2021 | 223305 | 0.090 |
Why?
|
| Retina | 1 | 2021 | 2660 | 0.080 |
Why?
|
| Counseling | 1 | 2018 | 1550 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 5 | 1998 | 1276 | 0.080 |
Why?
|
| Epiglottitis | 2 | 1986 | 19 | 0.080 |
Why?
|
| Laryngitis | 2 | 1986 | 27 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2014 | 7430 | 0.080 |
Why?
|
| Risk Assessment | 3 | 2015 | 24299 | 0.080 |
Why?
|
| Case-Control Studies | 5 | 2020 | 22248 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 3600 | 0.080 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2022 | 1897 | 0.080 |
Why?
|
| Forecasting | 1 | 2018 | 2936 | 0.080 |
Why?
|
| Saccule and Utricle | 1 | 2009 | 81 | 0.080 |
Why?
|
| Respiration Disorders | 1 | 1992 | 364 | 0.080 |
Why?
|
| Granulation Tissue | 1 | 2008 | 92 | 0.080 |
Why?
|
| Liver Transplantation | 1 | 2000 | 2416 | 0.080 |
Why?
|
| Tympanic Membrane Perforation | 1 | 2008 | 45 | 0.080 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1988 | 167 | 0.070 |
Why?
|
| Nucleoproteins | 1 | 1988 | 110 | 0.070 |
Why?
|
| Health Surveys | 1 | 2018 | 4055 | 0.070 |
Why?
|
| Cefaclor | 1 | 1987 | 8 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2015 | 1737 | 0.070 |
Why?
|
| DNA, Fungal | 2 | 1989 | 275 | 0.070 |
Why?
|
| Cefotaxime | 1 | 1987 | 36 | 0.070 |
Why?
|
| Cephalexin | 1 | 1987 | 37 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 6066 | 0.070 |
Why?
|
| Digestive System | 1 | 1988 | 244 | 0.070 |
Why?
|
| Blood Coagulation Tests | 1 | 2008 | 269 | 0.070 |
Why?
|
| Retinal Degeneration | 1 | 2011 | 413 | 0.070 |
Why?
|
| Stapedius | 1 | 2007 | 26 | 0.070 |
Why?
|
| Respiratory Tract Diseases | 2 | 2003 | 744 | 0.070 |
Why?
|
| Analgesics | 1 | 2014 | 1068 | 0.070 |
Why?
|
| RNA Splicing | 2 | 2022 | 903 | 0.070 |
Why?
|
| Fever | 2 | 2005 | 1607 | 0.070 |
Why?
|
| Cohort Studies | 8 | 2020 | 41706 | 0.070 |
Why?
|
| Incidence | 7 | 2021 | 21527 | 0.070 |
Why?
|
| Ear Ossicles | 1 | 2007 | 71 | 0.070 |
Why?
|
| Prospective Studies | 13 | 2016 | 54872 | 0.070 |
Why?
|
| Mastoid | 1 | 2007 | 100 | 0.070 |
Why?
|
| Epidermolysis Bullosa | 1 | 1986 | 29 | 0.070 |
Why?
|
| Halitosis | 1 | 2005 | 13 | 0.070 |
Why?
|
| Telomere-Binding Proteins | 1 | 2007 | 122 | 0.060 |
Why?
|
| Vaccination | 1 | 2018 | 3435 | 0.060 |
Why?
|
| Base Composition | 2 | 2020 | 291 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2017 | 1911 | 0.060 |
Why?
|
| Water Pollutants | 1 | 1985 | 25 | 0.060 |
Why?
|
| Genetic Complementation Test | 3 | 1996 | 556 | 0.060 |
Why?
|
| United States | 6 | 2020 | 72945 | 0.060 |
Why?
|
| Fuel Oils | 1 | 1985 | 36 | 0.060 |
Why?
|
| Chromosome Aberrations | 2 | 2024 | 1776 | 0.060 |
Why?
|
| Quality of Life | 4 | 2021 | 13476 | 0.060 |
Why?
|
| Facial Nerve Diseases | 1 | 2005 | 49 | 0.060 |
Why?
|
| Language Development | 2 | 2020 | 183 | 0.060 |
Why?
|
| Petroleum | 1 | 1985 | 82 | 0.060 |
Why?
|
| Coal | 1 | 1985 | 122 | 0.060 |
Why?
|
| Respiratory System | 1 | 1988 | 562 | 0.060 |
Why?
|
| Preoperative Care | 2 | 2008 | 2253 | 0.060 |
Why?
|
| Checklist | 1 | 2012 | 841 | 0.060 |
Why?
|
| Intubation, Intratracheal | 4 | 2000 | 1359 | 0.060 |
Why?
|
| Drinking | 1 | 2005 | 196 | 0.060 |
Why?
|
| Visual Fields | 1 | 2011 | 1063 | 0.060 |
Why?
|
| Eustachian Tube | 2 | 2001 | 99 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2350 | 0.060 |
Why?
|
| Encephalocele | 1 | 1985 | 135 | 0.060 |
Why?
|
| Facial Neoplasms | 1 | 2005 | 126 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2011 | 1090 | 0.060 |
Why?
|
| Ear, External | 1 | 2005 | 165 | 0.060 |
Why?
|
| Chromosome Pairing | 1 | 2003 | 46 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2006 | 496 | 0.060 |
Why?
|
| Prognosis | 6 | 2013 | 29959 | 0.050 |
Why?
|
| Papilloma | 1 | 1984 | 143 | 0.050 |
Why?
|
| Facial Injuries | 1 | 2005 | 190 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3431 | 0.050 |
Why?
|
| Replication Protein C | 1 | 2003 | 26 | 0.050 |
Why?
|
| Cloning, Molecular | 4 | 2003 | 4168 | 0.050 |
Why?
|
| Staphylococcus aureus | 3 | 2022 | 1429 | 0.050 |
Why?
|
| Logistic Models | 2 | 2015 | 13276 | 0.050 |
Why?
|
| Phylogeny | 3 | 2020 | 2840 | 0.050 |
Why?
|
| Referral and Consultation | 3 | 2021 | 3618 | 0.050 |
Why?
|
| Radiography | 2 | 2011 | 6968 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2007 | 606 | 0.050 |
Why?
|
| Recurrence | 4 | 2005 | 8507 | 0.050 |
Why?
|
| Dermoid Cyst | 1 | 2003 | 92 | 0.050 |
Why?
|
| Multivariate Analysis | 1 | 2015 | 12064 | 0.050 |
Why?
|
| Iatrogenic Disease | 1 | 2005 | 551 | 0.050 |
Why?
|
| Age Distribution | 2 | 2005 | 2869 | 0.050 |
Why?
|
| Fishes | 1 | 1985 | 607 | 0.050 |
Why?
|
| DNA, Viral | 2 | 2020 | 2201 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2021 | 18076 | 0.050 |
Why?
|
| Simplexvirus | 1 | 2005 | 805 | 0.050 |
Why?
|
| Mediastinitis | 1 | 2001 | 49 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 3796 | 0.050 |
Why?
|
| RNA Splice Sites | 1 | 2022 | 212 | 0.050 |
Why?
|
| Mitomycin | 1 | 2002 | 261 | 0.050 |
Why?
|
| Esophagus | 2 | 2001 | 1040 | 0.050 |
Why?
|
| Esophageal Perforation | 1 | 2001 | 65 | 0.050 |
Why?
|
| Water Pollutants, Chemical | 1 | 1985 | 356 | 0.050 |
Why?
|
| Chronic Disease | 8 | 2006 | 9358 | 0.050 |
Why?
|
| GPI-Linked Proteins | 1 | 2022 | 472 | 0.040 |
Why?
|
| Macaca fascicularis | 2 | 2020 | 908 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 1431 | 0.040 |
Why?
|
| Esophageal Stenosis | 1 | 2002 | 196 | 0.040 |
Why?
|
| Telomere | 1 | 2007 | 943 | 0.040 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1984 | 594 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2005 | 1733 | 0.040 |
Why?
|
| Middle Aged | 11 | 2020 | 223267 | 0.040 |
Why?
|
| Silent Information Regulator Proteins, Saccharomyces cerevisiae | 1 | 2000 | 62 | 0.040 |
Why?
|
| Bone Conduction | 2 | 2011 | 102 | 0.040 |
Why?
|
| Malocclusion | 1 | 2001 | 130 | 0.040 |
Why?
|
| Treatment Outcome | 11 | 2021 | 65286 | 0.040 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 100 | 0.040 |
Why?
|
| Facial Asymmetry | 1 | 2001 | 173 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5943 | 0.040 |
Why?
|
| Chromatin | 3 | 2006 | 2980 | 0.040 |
Why?
|
| Cricoid Cartilage | 1 | 2000 | 69 | 0.040 |
Why?
|
| Acupressure | 1 | 1999 | 13 | 0.040 |
Why?
|
| Protein Subunits | 1 | 2003 | 940 | 0.040 |
Why?
|
| Aged | 7 | 2020 | 171344 | 0.040 |
Why?
|
| Protein Isoforms | 1 | 2024 | 1716 | 0.040 |
Why?
|
| Base Sequence | 4 | 2009 | 12415 | 0.040 |
Why?
|
| Nursing Assessment | 1 | 1999 | 107 | 0.040 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2000 | 145 | 0.040 |
Why?
|
| Genes, Viral | 1 | 2020 | 654 | 0.040 |
Why?
|
| Jews | 1 | 2021 | 359 | 0.040 |
Why?
|
| Eating | 1 | 2005 | 1539 | 0.040 |
Why?
|
| Molecular Sequence Data | 5 | 2003 | 17609 | 0.040 |
Why?
|
| Otoscopes | 1 | 1998 | 13 | 0.040 |
Why?
|
| Histone Demethylases | 1 | 2021 | 328 | 0.040 |
Why?
|
| Developmental Disabilities | 1 | 2007 | 1519 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2019 | 275 | 0.040 |
Why?
|
| Risk Factors | 5 | 2020 | 74889 | 0.040 |
Why?
|
| Cell Nucleus | 3 | 2003 | 2875 | 0.040 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2022 | 833 | 0.040 |
Why?
|
| Decision Making | 1 | 2012 | 3951 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 13411 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 2003 | 1159 | 0.040 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 2 | 1996 | 16 | 0.040 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2000 | 296 | 0.040 |
Why?
|
| Heterozygote | 3 | 2011 | 2795 | 0.040 |
Why?
|
| Primates | 1 | 2020 | 519 | 0.040 |
Why?
|
| Lysogeny | 1 | 2017 | 68 | 0.030 |
Why?
|
| Infant, Premature | 1 | 1987 | 2120 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2003 | 2746 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 454 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2019 | 640 | 0.030 |
Why?
|
| Histones | 3 | 2003 | 2595 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 1998 | 314 | 0.030 |
Why?
|
| Transgenes | 1 | 2020 | 1014 | 0.030 |
Why?
|
| Exons | 1 | 2022 | 2392 | 0.030 |
Why?
|
| Electrodes, Implanted | 1 | 2021 | 835 | 0.030 |
Why?
|
| Injections, Intravenous | 2 | 2001 | 1377 | 0.030 |
Why?
|
| Familial Mediterranean Fever | 1 | 2016 | 66 | 0.030 |
Why?
|
| Turkey | 1 | 2016 | 256 | 0.030 |
Why?
|
| NAD | 1 | 2000 | 617 | 0.030 |
Why?
|
| Nausea | 1 | 1999 | 681 | 0.030 |
Why?
|
| DNA Helicases | 1 | 2021 | 854 | 0.030 |
Why?
|
| Cicatrix | 1 | 2002 | 798 | 0.030 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2016 | 139 | 0.030 |
Why?
|
| Otitis Externa | 1 | 1995 | 17 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2024 | 1886 | 0.030 |
Why?
|
| Vomiting | 1 | 1999 | 652 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2000 | 712 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 1805 | 0.030 |
Why?
|
| Papain | 1 | 1975 | 66 | 0.030 |
Why?
|
| Ear Cartilage | 1 | 1995 | 62 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 10816 | 0.030 |
Why?
|
| Ligases | 1 | 2017 | 330 | 0.030 |
Why?
|
| Tracheal Stenosis | 2 | 2002 | 228 | 0.030 |
Why?
|
| Bacteria | 1 | 1986 | 2212 | 0.030 |
Why?
|
| Palatine Tonsil | 1 | 1995 | 193 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2005 | 2978 | 0.030 |
Why?
|
| Acupuncture Therapy | 1 | 1999 | 467 | 0.030 |
Why?
|
| Dependovirus | 1 | 2020 | 720 | 0.030 |
Why?
|
| Patient Care Team | 2 | 2012 | 2519 | 0.030 |
Why?
|
| Likelihood Functions | 2 | 2009 | 993 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1998 | 1677 | 0.030 |
Why?
|
| Porins | 1 | 1994 | 78 | 0.030 |
Why?
|
| S Phase | 2 | 2006 | 424 | 0.030 |
Why?
|
| Codeine | 1 | 2014 | 52 | 0.030 |
Why?
|
| Animals | 10 | 2024 | 168939 | 0.030 |
Why?
|
| Quinolinic Acid | 1 | 1994 | 67 | 0.030 |
Why?
|
| Transferrin | 1 | 1995 | 283 | 0.030 |
Why?
|
| Apnea | 1 | 1995 | 193 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2024 | 5388 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2020 | 1308 | 0.030 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 39312 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2003 | 1851 | 0.030 |
Why?
|
| Trachea | 1 | 2000 | 1094 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2018 | 1824 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 1997 | 768 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 1998 | 1459 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2021 | 2045 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1993 | 212 | 0.030 |
Why?
|
| Tongue | 1 | 1995 | 406 | 0.020 |
Why?
|
| Mutagenesis | 1 | 1996 | 1228 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2019 | 1756 | 0.020 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3724 | 0.020 |
Why?
|
| DNA Primers | 1 | 1996 | 2826 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 2 | 1989 | 205 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1989 | 548 | 0.020 |
Why?
|
| Time Factors | 5 | 2005 | 40149 | 0.020 |
Why?
|
| Genome, Bacterial | 1 | 2017 | 796 | 0.020 |
Why?
|
| Sensitivity and Specificity | 4 | 2015 | 14653 | 0.020 |
Why?
|
| Hypertrophy | 1 | 2013 | 562 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 4780 | 0.020 |
Why?
|
| Sequence Analysis | 1 | 2011 | 240 | 0.020 |
Why?
|
| Medical History Taking | 1 | 1995 | 779 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 987 | 0.020 |
Why?
|
| Visual Cortex | 1 | 1998 | 1081 | 0.020 |
Why?
|
| Administration, Topical | 3 | 2002 | 702 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2000 | 2856 | 0.020 |
Why?
|
| Dark Adaptation | 1 | 2011 | 224 | 0.020 |
Why?
|
| Vocal Cords | 1 | 1995 | 520 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1997 | 1480 | 0.020 |
Why?
|
| Deglutition | 1 | 1992 | 208 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2020 | 3401 | 0.020 |
Why?
|
| Mutagenesis, Insertional | 1 | 1993 | 663 | 0.020 |
Why?
|
| Electromyography | 2 | 2009 | 1398 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2011 | 203 | 0.020 |
Why?
|
| Zebrafish | 1 | 2021 | 3035 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2017 | 1801 | 0.020 |
Why?
|
| Biopsy, Needle | 2 | 2011 | 1615 | 0.020 |
Why?
|
| Erythrocytes | 2 | 1976 | 2412 | 0.020 |
Why?
|
| Monocytes | 2 | 1976 | 2599 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2021 | 3667 | 0.020 |
Why?
|
| Endoscopy | 1 | 1999 | 1854 | 0.020 |
Why?
|
| HIV Infections | 1 | 2015 | 17532 | 0.020 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1988 | 17 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1984 | 4050 | 0.020 |
Why?
|
| Temperature | 2 | 2006 | 2231 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2024 | 14473 | 0.020 |
Why?
|
| Ion Transport | 1 | 2009 | 322 | 0.020 |
Why?
|
| Cefixime | 1 | 1987 | 13 | 0.020 |
Why?
|
| Cysts | 1 | 1993 | 685 | 0.020 |
Why?
|
| ROC Curve | 1 | 2015 | 3621 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 3738 | 0.020 |
Why?
|
| Evoked Potentials, Auditory, Brain Stem | 1 | 2009 | 256 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 1211 | 0.020 |
Why?
|
| Tympanoplasty | 1 | 1987 | 73 | 0.020 |
Why?
|
| Neurons | 2 | 1998 | 9515 | 0.020 |
Why?
|
| Visual Perception | 1 | 2015 | 1392 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1988 | 1305 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9464 | 0.020 |
Why?
|
| Pain | 1 | 2022 | 5098 | 0.020 |
Why?
|
| Phosphoproteins | 2 | 2006 | 2448 | 0.020 |
Why?
|
| Infant, Premature, Diseases | 1 | 1992 | 712 | 0.020 |
Why?
|
| Cadaver | 1 | 2011 | 1362 | 0.020 |
Why?
|
| Infant, Low Birth Weight | 2 | 1992 | 870 | 0.020 |
Why?
|
| Algorithms | 3 | 2017 | 14073 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2018 | 3957 | 0.020 |
Why?
|
| Age Factors | 2 | 2015 | 18397 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2019 | 16044 | 0.020 |
Why?
|
| Chlorides | 1 | 2009 | 666 | 0.020 |
Why?
|
| Parents | 1 | 2020 | 3592 | 0.020 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2006 | 142 | 0.020 |
Why?
|
| Corynebacterium | 1 | 1986 | 49 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2011 | 706 | 0.020 |
Why?
|
| Neuroma, Acoustic | 1 | 2010 | 456 | 0.020 |
Why?
|
| Haemophilus Infections | 1 | 1986 | 94 | 0.020 |
Why?
|
| Mice | 3 | 2024 | 81898 | 0.020 |
Why?
|
| Haemophilus influenzae | 1 | 1986 | 177 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1993 | 2093 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2009 | 1529 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2009 | 529 | 0.020 |
Why?
|
| Xenopus laevis | 1 | 2009 | 966 | 0.020 |
Why?
|
| Drug Evaluation | 1 | 1986 | 642 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 18329 | 0.010 |
Why?
|
| Lung Volume Measurements | 1 | 1985 | 381 | 0.010 |
Why?
|
| Sphenoid Bone | 1 | 1985 | 176 | 0.010 |
Why?
|
| Bronchoscopy | 3 | 2000 | 913 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 1976 | 4559 | 0.010 |
Why?
|
| Otoscopy | 1 | 2004 | 40 | 0.010 |
Why?
|
| Oocytes | 1 | 2009 | 1168 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2020 | 8065 | 0.010 |
Why?
|
| Mastoiditis | 1 | 1984 | 37 | 0.010 |
Why?
|
| Ear Diseases | 1 | 1986 | 181 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 2 | 1995 | 1972 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2010 | 1050 | 0.010 |
Why?
|
| Boston | 1 | 2016 | 9346 | 0.010 |
Why?
|
| Reference Values | 1 | 2011 | 4914 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 463 | 0.010 |
Why?
|
| Genome, Fungal | 1 | 2004 | 203 | 0.010 |
Why?
|
| Pulmonary Ventilation | 1 | 1985 | 374 | 0.010 |
Why?
|
| Protein Binding | 2 | 2007 | 9326 | 0.010 |
Why?
|
| G1 Phase | 1 | 2004 | 403 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2009 | 1969 | 0.010 |
Why?
|
| Tidal Volume | 1 | 1985 | 519 | 0.010 |
Why?
|
| Speech Disorders | 1 | 2004 | 178 | 0.010 |
Why?
|
| China | 1 | 2009 | 2386 | 0.010 |
Why?
|
| Language Development Disorders | 1 | 2004 | 194 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2004 | 565 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 2011 | 11062 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2012 | 6329 | 0.010 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 1984 | 243 | 0.010 |
Why?
|
| Choanal Atresia | 1 | 2002 | 41 | 0.010 |
Why?
|
| Cross-Sectional Studies | 3 | 2013 | 26309 | 0.010 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 874 | 0.010 |
Why?
|
| Canada | 1 | 2007 | 2126 | 0.010 |
Why?
|
| Pediatrics | 1 | 2016 | 3614 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2006 | 724 | 0.010 |
Why?
|
| Sudden Infant Death | 1 | 2003 | 293 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1985 | 1088 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1995 | 3530 | 0.010 |
Why?
|
| Tongue Neoplasms | 1 | 1982 | 185 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2011 | 3576 | 0.010 |
Why?
|
| Mass Screening | 1 | 2016 | 5454 | 0.010 |
Why?
|
| Nasal Polyps | 1 | 1985 | 412 | 0.010 |
Why?
|
| Intubation, Gastrointestinal | 1 | 2001 | 166 | 0.010 |
Why?
|
| Laryngostenosis | 1 | 2002 | 168 | 0.010 |
Why?
|
| Sirtuin 2 | 1 | 2000 | 93 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 1080 | 0.010 |
Why?
|
| Oncogenes | 1 | 1985 | 1232 | 0.010 |
Why?
|
| Psychotherapy | 1 | 1969 | 1648 | 0.010 |
Why?
|
| Respiratory Sounds | 1 | 2003 | 702 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2003 | 2177 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 1176 | 0.010 |
Why?
|
| Shock, Septic | 1 | 1986 | 772 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2001 | 398 | 0.010 |
Why?
|
| DNA, Ribosomal | 1 | 2000 | 300 | 0.010 |
Why?
|
| Polymyxin B | 1 | 1998 | 44 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2015 | 15425 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1986 | 6306 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2007 | 2133 | 0.010 |
Why?
|
| Sirtuin 1 | 1 | 2000 | 247 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 1326 | 0.010 |
Why?
|
| Neomycin | 1 | 1998 | 94 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2000 | 220 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2003 | 614 | 0.010 |
Why?
|
| Drainage | 1 | 1984 | 1182 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2000 | 428 | 0.010 |
Why?
|
| Tomography, Optical Coherence | 1 | 2011 | 2954 | 0.010 |
Why?
|
| Gestational Age | 1 | 1987 | 3617 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 1986 | 1390 | 0.010 |
Why?
|
| Communication | 1 | 2012 | 3905 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2003 | 3073 | 0.010 |
Why?
|
| Sirtuins | 1 | 2000 | 322 | 0.010 |
Why?
|
| Causality | 1 | 2003 | 1252 | 0.010 |
Why?
|
| Patient Compliance | 1 | 1987 | 2694 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 1998 | 8715 | 0.010 |
Why?
|
| Respiratory Insufficiency | 1 | 1986 | 1241 | 0.010 |
Why?
|
| Concanavalin A | 1 | 1976 | 189 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12430 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 3759 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 7841 | 0.010 |
Why?
|
| Sinusitis | 1 | 1985 | 997 | 0.010 |
Why?
|
| Immune Adherence Reaction | 1 | 1975 | 29 | 0.010 |
Why?
|
| Hemagglutination Tests | 1 | 1975 | 76 | 0.010 |
Why?
|
| Cochlear Aqueduct | 1 | 1995 | 7 | 0.010 |
Why?
|
| Oval Window, Ear | 1 | 1995 | 21 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2000 | 2274 | 0.010 |
Why?
|
| Linear Models | 1 | 2005 | 5873 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 1524 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2013 | 11924 | 0.010 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1975 | 341 | 0.010 |
Why?
|
| Rh-Hr Blood-Group System | 1 | 1975 | 64 | 0.010 |
Why?
|
| Binding Sites, Antibody | 1 | 1975 | 340 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2003 | 4618 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2003 | 1893 | 0.010 |
Why?
|
| Immune Sera | 1 | 1975 | 605 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2002 | 1540 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1985 | 10745 | 0.010 |
Why?
|
| alpha Karyopherins | 1 | 1994 | 42 | 0.010 |
Why?
|
| Audiometry, Evoked Response | 1 | 1994 | 45 | 0.010 |
Why?
|
| Round Window, Ear | 1 | 1994 | 47 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1994 | 224 | 0.010 |
Why?
|
| Chinchilla | 1 | 1994 | 77 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 1994 | 816 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1985 | 2535 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1994 | 355 | 0.010 |
Why?
|
| Mouth Breathing | 1 | 1992 | 25 | 0.010 |
Why?
|
| Prevalence | 1 | 1989 | 15835 | 0.010 |
Why?
|
| Maxillofacial Development | 1 | 1992 | 87 | 0.010 |
Why?
|
| Complement System Proteins | 1 | 1975 | 738 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2011 | 12808 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2003 | 12795 | 0.010 |
Why?
|
| Drug Combinations | 1 | 1998 | 2085 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1984 | 8540 | 0.010 |
Why?
|
| Sepsis | 1 | 1986 | 2604 | 0.010 |
Why?
|
| Immunization | 1 | 1975 | 1218 | 0.010 |
Why?
|
| Wound Healing | 1 | 2002 | 2800 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2007 | 14762 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 59548 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1998 | 1838 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 1975 | 1527 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 1976 | 3093 | 0.010 |
Why?
|
| Stents | 1 | 2002 | 3193 | 0.010 |
Why?
|
| DNA | 1 | 2003 | 7210 | 0.010 |
Why?
|
| Pulmonary Edema | 1 | 1992 | 409 | 0.010 |
Why?
|
| Enuresis | 1 | 1969 | 45 | 0.000 |
Why?
|
| Rabbits | 1 | 1975 | 4752 | 0.000 |
Why?
|
| Comorbidity | 1 | 2003 | 10580 | 0.000 |
Why?
|
| Mental Disorders | 1 | 1969 | 6869 | 0.000 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 1989 | 121 | 0.000 |
Why?
|
| Blotting, Western | 1 | 1995 | 5022 | 0.000 |
Why?
|
| Delivery of Health Care | 1 | 2004 | 5367 | 0.000 |
Why?
|
| Dimethylhydrazines | 1 | 1985 | 12 | 0.000 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 1984 | 9407 | 0.000 |
Why?
|
| Arnold-Chiari Malformation | 1 | 1987 | 159 | 0.000 |
Why?
|
| Poly A | 1 | 1985 | 180 | 0.000 |
Why?
|
| Nucleosomes | 1 | 1989 | 492 | 0.000 |
Why?
|
| Amoxicillin | 1 | 1985 | 179 | 0.000 |
Why?
|
| RNA, Neoplasm | 1 | 1985 | 748 | 0.000 |
Why?
|
| Injections | 1 | 1985 | 839 | 0.000 |
Why?
|
| Cell Cycle | 1 | 1989 | 2925 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1985 | 1741 | 0.000 |
Why?
|
| Drug Administration Schedule | 1 | 1985 | 4853 | 0.000 |
Why?
|
| Administration, Oral | 1 | 1985 | 4019 | 0.000 |
Why?
|
| Receptors, Concanavalin A | 1 | 1976 | 11 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1985 | 6225 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1976 | 655 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1982 | 2901 | 0.000 |
Why?
|
| Anxiety | 1 | 1969 | 4668 | 0.000 |
Why?
|
| Risk | 1 | 1985 | 9602 | 0.000 |
Why?
|
| Phagocytosis | 1 | 1976 | 1526 | 0.000 |
Why?
|
| Lymph Nodes | 1 | 1982 | 3468 | 0.000 |
Why?
|
| Kinetics | 1 | 1976 | 6288 | 0.000 |
Why?
|
| Depression | 1 | 1969 | 8225 | 0.000 |
Why?
|
| Aging | 1 | 1987 | 8728 | 0.000 |
Why?
|
| Binding Sites | 1 | 1976 | 6013 | 0.000 |
Why?
|